SCHEMBL2397962

SCHEMBL2397962

CCCCCCCCCCO[Si](OCCCCCCCCCC)(OCCCCCCCCCC)OCCCCCCCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.47
TSHR P16473 1/20 0.47
MEN1 O00255 1/20 0.42
HTT P42858 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.42
CA1 P00915 8/20 0.41
CA2 P00918 8/20 0.41
CA9 Q16790 7/20 0.41
LPAR3 Q9UBY5 6/20 0.41
LPAR2 Q9HBW0 5/20 0.41
CA12 O43570 3/20 0.41
CA7 P43166 3/20 0.41
CA14 Q9ULX7 3/20 0.41
LPAR1 Q92633 2/20 0.41
CA3 P07451 2/20 0.41
CA4 P22748 2/20 0.41
CA6 P23280 2/20 0.41
CA5A P35218 2/20 0.41
CA5B Q9Y2D0 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8885434 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL29144607 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL28566316 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL9119727 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL11592491 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL11572901 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL766409 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL77168 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL7172026 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A
SCHEMBL4810672 1.00 THRB (0.47) THRBTSHRMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118183820-A Cu/SiO2Comprehensive utilization method of waste catalyst 湖北兴瑞硅材料有限公司 2024-06-14 CN disclosed
CN-116217606-A Short-process preparation method of alkoxy silane 湖北兴瑞硅材料有限公司 2023-06-06 CN disclosed
CN-116162106-A Method for synthesizing alkoxy silane by carbon dioxide assisted catalysis 湖北兴瑞硅材料有限公司 2023-05-26 CN disclosed
CN-116162107-A Method for dehydrating agent and assisting in catalytic synthesis of alkoxy silane 湖北兴瑞硅材料有限公司 2023-05-26 CN disclosed
CN-107034463-B The preparation method of directionality zeolite membrane 华颖精矽科技股份有限公司 2019-03-29 CN disclosed
US-9822011-B2 Method for fabricating oriented zeolite film HAWING GEMS TECHNOLOGY CO., LTD. (TW) 2017-11-21 US disclosed
CN-107034463-A The preparation method of directionality zeolite membrane 华颖精矽科技股份有限公司 2017-08-11 CN disclosed
US-9657039-B2 Production method for alkoxysilanes NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2017-05-23 US disclosed
US-20160236942-A1 Method for Fabricating Oriented Zeolite Film HAWING GEMS TECHNOLOGY CO. LTD. (TW) 2016-08-18 US disclosed
US-20160002271-A1 PRODUCTION METHOD FOR ALKOXYSILANES NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2016-01-07 US disclosed
US-20110223096-A1 CATALYST FOR OXIDATION REACTIONS IN THE PRESENCE OF HYDROGEN CHLORIDE AND/OR CHLORINE AND METHOD FOR THE PRODUCTION THEREOF, AND THE USE THEREOF BAYER TECHNOLOGY SERVICES GMBH (DE) 2011-09-15 US disclosed
US-6825366-B2 DIRECT GAS PHASE PARTIAL OXIDATION OF OLEFINS BY MOLECULAR OXYGEN TO EPOXIDES USING NANOMETER SIZE GOLD ON SUPPORT MATERIAL SELECTED FROM FOR EXAMPLE SCANDIUM, YTTRIUM, LANTHANIDE, ZIRCONIUM, HAFNIUM, VANADIUM BAYER AKTIENGESELLSCHAFT (DE) 2004-11-30 US disclosed
EP-1244738-B1 BIOMIMETIC SILICONE ELASTOMERS XIOMATERIA LTD (GB) 2003-06-11 EP disclosed
US-20030100778-A1 Epoxidation catalysts containing metals of the lanthanoide series BAYER AKTIENGESELLSCHAFT (DE) 2003-05-29 US disclosed
US-20030060643-A1 Process for the epoxidation of olefins using gold-containing catalyst BAYER AKTIENGESELLSCHAFT (DE) 2003-03-27 US disclosed
EP-1257357-A1 PROCESS FOR THE EPOXIDATION OF OLEFINS USING GOLD-CONTAINING CATALYSTS Bayer Aktiengesellschaft (DE) 2002-11-20 EP disclosed
EP-1125632-A1 Process for the epoxidation of olefins using gold-containing catalysts Bayer Aktiengesellschaft (DE) 2001-08-22 EP disclosed
EP-1125933-A1 Epoxidation catalyst containing metals of the lanthanoide series Bayer Aktiengesellschaft (DE) 2001-08-22 EP disclosed
WO-2001058585-A1 PROCESS FOR THE EPOXIDATION OF OLEFINS USING GOLD-CONTAINING CATALYSTS BAYER AKTIENGESELLSCHAFT (DE) 2001-08-16 WO disclosed
US-4092465-A PRESSURE SENSITIVE, IMPROVED CREEP RESISTANCE PHILLIPS PETROLEUM COMPANY (US) 1978-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160002271-A1 PRODUCTION METHOD FOR ALKOXYSILANES MSMO1, MGAM, MACO1 THRB 4555/4885TSHR 2938/4885MEN1 218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.